Chai Discovery
Chai Discovery develops artificial intelligence models and software for protein engineering and molecular design. Its platform enables researchers to design antibodies, miniproteins, and other biomolecules from target structures or sequences while supporting different antibody formats, framework sequences, epitope selection, and molecular design criteria. The company’s technology is used to predict molecular interactions, generate de novo protein designs, and support therapeutic research by reducing experimental screening and accelerating candidate evaluation. Chai Discovery also provides controlled access to its AI models for commercial and academic research through a web-based platform.
Funding
Every round, secondary, debt facility or acquisition involving Chai Discovery that AI Lounge tracks, newest first. Latest: Series C on Jul 15, 2026.
Timeline · 2
In the news
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in